Scientific paper - Original scientific paper
Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes
International Journal of Cardiology, 301 (2020); 90-95. https://doi.org/10.1016/j.ijcard.2019.10.035

Lucijanić, Marko; Jurin, Ivana; Jurin, Hrvoje; Lucijanić, Tomo; Starčević, Boris; Skelin, Marko; Glasnović, Anton; Ćatić, Jasmina; Jurišić, Anđela; Hadžibegović, Irzal

Cite this document

Lucijanić, M., Jurin, I., Jurin, H., Lucijanić, T., Starčević, B., Skelin, M. ... Hadžibegović, I. (2020). Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes. International Journal of Cardiology, 301., 90-95. doi: 10.1016/j.ijcard.2019.10.035

Lucijanić, Marko, et al. "Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes." International Journal of Cardiology, vol. 301, 2020, pp. 90-95. https://doi.org/10.1016/j.ijcard.2019.10.035

Lucijanić, Marko, Ivana Jurin, Hrvoje Jurin, Tomo Lucijanić, Boris Starčević, Marko Skelin, Anton Glasnović, Jasmina Ćatić, Anđela Jurišić and Irzal Hadžibegović. "Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes." International Journal of Cardiology 301 (2020): 90-95. https://doi.org/10.1016/j.ijcard.2019.10.035

Lucijanić, M., et al. (2020) 'Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes', International Journal of Cardiology, 301, pp. 90-95. doi: 10.1016/j.ijcard.2019.10.035

Lucijanić M, Jurin I, Jurin H, Lucijanić T, Starčević B, Skelin M, and sur.. Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes. International Journal of Cardiology [Internet]. 2020 February 15 [cited 2024 April 14];301:90-95. doi: 10.1016/j.ijcard.2019.10.035

M. Lucijanić, et al., "Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes", International Journal of Cardiology, vol. 301, pp. 90-95, February 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:866450. [Accessed: 14 April 2024]